Immune to Cancer: The CRI Blog
-
New Biomarker ‘Bim’ Could Enable Smarter Treatment for Melanoma Patients
Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who…
-
Third Immunotherapy Option Approved for Bladder Cancer Patients
On February 2, nivolumab (Opdivo®, Bristol-Myers Squibb) became the newest FDA-approved immunotherapy available for patients with bladder…
-
Immunotherapy Shows Promise Against Previously Untreatable Stomach Cancer
Nivolumab improves survival in patients with advanced stomach cancer.
-
Focused Ultrasound Foundation to Host Free Webinar on Recent Advances in Cancer Immunotherapy
CRI’s CEO and director of scientific affairs will discuss latest research on focused ultrasound and immunotherapy combination…
-
2016: The Year of Cancer Immunotherapy
New immunotherapy approvals, “Advance of the Year” recognition, and the partnerships of the future.
-
Remembering Six-Time Jeopardy! Champion Cindy Stowell
Cindy, who passed from stage 4 colon cancer, has donated her winnings to the Cancer Research Institute.
-
Young Adults “Chasing Cancer”
Guest blogger Ariella Chivil recaps her visit at The Washington Post Chasing Cancer Summit.
-
Immuno-Oncology 360°: Connecting Science & Business to Advance Immunotherapy
The third annual IO360° conferences comes to NYC February 2017.
-
Remembering Renowned Immunology Pioneer Georg Klein
The longtime member of CRI’s Scientific Advisory Council sought to save lives through research and education.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.